Free Trial

Quoin Pharmaceuticals (QNRX) SEC Filings & 10K Form

Quoin Pharmaceuticals logo
$6.10 -0.51 (-7.72%)
Closing price 05/2/2025 03:51 PM Eastern
Extended Trading
$6.52 +0.42 (+6.89%)
As of 05/2/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Quoin Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/04/2025
7:30 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form POS AM
03/20/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
3:43 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/28/2025
3:44 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
3:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:34 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
4:20 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
01/02/2025
4:20 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
12/27/2024
4:15 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:17 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
8:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B4
12/22/2024
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
12/19/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1/A
12/11/2024
3:20 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
5:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
12/10/2024
3:45 PM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:46 PM
Leong Natalie Ee Mun (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
SEMBER MICHAEL T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:49 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:50 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:51 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:52 PM
Cooper Joseph Patrick (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:23 PM
Lind Global Fund II LP (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
4:04 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
10/31/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form ARS
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form DEF 14A
10/11/2024
3:56 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form PRE 14A
09/30/2024
5:07 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
11:03 AM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

09/05/2024
11:06 AM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:32 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
06/07/2024
11:24 AM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:QNRX) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners